Scan to Download
One power score. Smarter investment decisions
CytoMed Therapeutics Ltd
GDTC2.110USD
+0.120+6.03%
Close 11/05, 16:00（ET）Quotes delayed by 15 min
2.110USD+2.110After-hours 11/05, 20:00 (ET)
24.33MMarket Cap
--P/E TTM
CytoMed Therapeutics Ltd
2.110
+0.120+6.03%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-15.90%-1.20M
41.28%-907.29K
-41.14%-1.03M
-278.68%-1.54M
14.10%-730.99K
19.21%-408.00K
-158.71%-850.98K
-35.17%-505.02K
---328.93K
---373.61K
Net income from continuing operations
24.43%-1.10M
47.29%-847.25K
9.25%-1.45M
-116.44%-1.61M
-108.57%-1.60M
1.03%-742.66K
28.07%-765.88K
-97.54%-750.38K
---1.06M
---379.87K
Operating gains losses
-1.50%128.78K
-14.13%129.88K
-13.47%130.74K
6.15%151.25K
20.02%151.09K
20.82%142.49K
9.02%125.88K
17.35%117.93K
--115.47K
--100.50K
Other non-cash items
47.71%-97.16K
-401.31%-148.30K
-126.16%-185.81K
-52.67%49.22K
613.59%710.23K
-16.08%103.98K
-132.13%-138.29K
4220.65%123.90K
--430.42K
--2.87K
Change in working capital
-68.75%84.75K
32.30%-133.33K
1822.05%271.19K
-389.89%-196.93K
105.06%14.11K
1826.31%67.93K
-246.95%-279.09K
103.63%3.53K
--189.93K
---97.11K
-Change in receivables
-212.27%-92.04K
136.95%32.17K
154.24%81.98K
-305.45%-87.07K
48.60%-151.15K
248.50%42.38K
-812.71%-294.05K
66.73%-28.54K
---32.22K
---85.78K
-Change in inventory
----
----
----
----
----
----
-51.13%59.99K
49.45%-58.84K
--122.76K
---116.40K
-Change in payables and accrued expense
-47.88%98.62K
-50.65%-165.50K
14.49%189.21K
-529.94%-109.86K
467.00%165.26K
-71.89%25.55K
-145.31%-45.03K
-13.47%90.91K
--99.39K
--105.06K
-Change in other current liabilities
--78.18K
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-15.90%-1.20M
41.28%-907.29K
-41.14%-1.03M
-278.68%-1.54M
14.10%-730.99K
19.21%-408.00K
-158.71%-850.98K
-35.17%-505.02K
---328.93K
---373.61K
Investing cash flow
Net cash from continuing investing activities
2214.28%699.55K
5453.06%708.37K
-21.16%30.23K
-95.95%12.76K
-90.96%38.34K
3016.02%314.91K
351.38%424.19K
-90.02%10.11K
--93.98K
--101.23K
Capital expenditures
2214.28%699.55K
5453.06%708.37K
-21.91%30.23K
-95.95%12.76K
-90.87%38.71K
3016.02%314.91K
351.38%424.19K
-90.02%10.11K
--93.98K
--101.23K
Net cash flow from disposal of fixed assets
1976.07%627.55K
5453.06%708.37K
-21.16%30.23K
-95.95%12.76K
-90.96%38.34K
3016.02%314.91K
434.81%424.19K
-89.94%10.11K
--79.32K
--100.46K
Net cash flow from intangible asset transactions
--72.00K
----
----
----
--0.00
----
-100.00%0.00
-100.00%0.00
--14.66K
--763.05
Net cash flow from investment products
--252.96K
----
----
----
-100.00%0.00
100.00%0.00
195.93%180.04K
---176.59K
---187.67K
--0.00
Net cash flow from other investing activities
235.18%2.75M
81.23%-760.96K
---2.03M
---4.05M
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
211.58%2.30M
63.87%-1.47M
-5285.17%-2.06M
-1191.29%-4.07M
90.96%-38.34K
-68.67%-314.91K
-50.61%-424.19K
-84.43%-186.70K
---281.65K
---101.23K
Financing cash flow
Cash flow from continuous financing activities
-575.33%-18.99K
-100.19%-15.36K
-99.53%3.99K
28621.89%8.16M
247.78%847.37K
-100.99%-28.62K
-67.84%243.65K
308.91%2.90M
--757.54K
--709.50K
Net cash flow from debt Issuance/repayment
-575.33%-18.99K
94.04%-15.36K
105.90%3.99K
-799.97%-257.59K
-127.77%-67.65K
-10.27%-28.62K
-35.71%243.65K
-103.66%-25.96K
--379.01K
--709.50K
Net cash flow from common stock issuance/repurchase
----
-100.00%0.00
-100.00%0.00
--8.42M
--915.02K
-100.00%0.00
-100.00%0.00
--1.46M
--378.53K
--0.00
Net cash flow from other financing activities
----
----
----
----
--0.00
-100.00%0.00
--0.00
--1.46M
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-575.33%-18.99K
-100.19%-15.36K
-99.53%3.99K
28621.89%8.16M
247.78%847.37K
-100.99%-28.62K
-67.84%243.65K
308.91%2.90M
--757.54K
--709.50K
Net cash flow
Beginning cash balance
-67.86%2.46M
495.07%7.00M
588.62%7.66M
-37.24%1.18M
-61.71%1.11M
189.39%1.87M
457.42%2.91M
143.30%647.84K
--521.47K
--266.27K
Current period cash flow changes
136.41%1.13M
-191.83%-2.34M
-4566.54%-3.09M
432.41%2.54M
106.71%69.27K
-134.73%-765.21K
-793.88%-1.03M
865.57%2.20M
--148.73K
--228.18K
Effect of exchange rate changes
2763.40%37.47K
755.62%56.13K
83.96%-1.41K
37.41%-8.56K
-1748.26%-8.77K
-117.01%-13.68K
-126.80%-474.52
2.80%-6.30K
--1.77K
---6.48K
Ending cash balance
-21.45%3.59M
25.41%4.67M
286.57%4.57M
235.27%3.72M
-36.94%1.18M
-61.08%1.11M
179.73%1.87M
476.61%2.85M
--670.20K
--494.45K
Free cash flow
-78.48%-1.90M
-3.72%-1.62M
-37.97%-1.06M
-115.48%-1.56M
39.64%-769.70K
-40.34%-722.91K
-201.53%-1.28M
-8.48%-515.12K
---422.90K
---474.84K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
